A researcher at Duke University, speaks out after her NIH grant for sickle cell research was terminated. The $750,000 funding ...

Beam Therapeutics Inc. (NASDAQ:BEAM) ranks among the best CRISPR stocks to buy. On June 13, Beam Therapeutics Inc.

A doctor says she’s scrambling to figure out how she’ll continue her work helping sickle cell disease patients after the ...

Extreme pain, known as a pain crisis, is one of the hallmark symptoms of SCD. With frequent hospitalizations, chronic pain ...

The sickle cell disease treatment market is experiencing significant expansion, driven by increasing disease awareness, rising prevalence, and breakthrough therapies from key pharmaceutical players, ...

June 19th is not only Juneteenth, it is also World Sickle Cell Awareness Day. Sickle cell disease affects about 100,000 ...

Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new ...

Families of those who have sickle cell disease in the Philadelphia area are pushing for more research and a cure.

With gene therapy in the works, clinical trials for sickle cell disease still lack Black American participants.

The condition mostly affects those from African and Caribbean backgrounds but Victoria Ekanoye says it can affect anyone. | ...

In a sharply divided political climate, San Rocco Therapeutics (SRT) has done what few thought possible—earned support from both the highest levels of Washington and from those who distrust it.

Nicole and Kyle Law have a strong bond. “She’s always there for me whenever I need her. Being sick and being healthy, too.